In the current environment we have been living in since Christmas Eve, yes a very short time, an old adage comes to mind. Do not confuse brains with a bull market. This will always be true, but as all boats are lifted by the rising tide, leaders will ascend more than others, and the astute investors will be quick to recognize this. Below is an example of NVCR and how it appeared in our 1/7 Healthcare Report.

Name more than doubled during a 20 of 25 week winning streak the weeks ending between 4/13-9/28/18. NVCR is a biotech company UNCH YTD and higher by 65% over the last one year period. Earnings have been mostly lower with losses of 19, 1.7 and 4.4% on 10/25, 7/26 and 2/22 and a gain of 9.7% on 4/26. The stock is now consolidating a very large loss of 45% during a 4 week losing streak the weeks ending between 10/5-26. It is higher 4 of the last 6 weeks, with 2 double digit weekly gains and still trades 37% off most recent 52 week highs. Enter NVCR with buy stop above symmetrical triangle, that aligns with rising 200 day SMA, at 34.30.

Trigger NVCR 34.30.  Stop 32.

Taking a present look at the name it rose 47.5% from the recommended entry to the highs made just above 50 last week. It has fallen each day this week, and has dropped more than 5% this week so far, including 2.1% on a firm tape Wednesday. That can be forgiven as it has advanced by a combined 56% during the current 5 week winning streak. A new add on entry is taking shape in the form of a handle on a deep cup base and add to through 50.68.

If you liked what you read why not visit www.chartsmarter.com.

This article requires a Chartsmarter membership. Please click here to join.

In the current environment we have been living in since Christmas Eve, yes a very short time, an old adage comes to mind. Do not confuse brains with a bull market. This will always be true, but as all boats are lifted by the rising tide, leaders will ascend more than others, and the astute investors will be quick to recognize this. Below is an example of NVCR and how it appeared in our 1/7 Healthcare Report.

Name more than doubled during a 20 of 25 week winning streak the weeks ending between 4/13-9/28/18. NVCR is a biotech company UNCH YTD and higher by 65% over the last one year period. Earnings have been mostly lower with losses of 19, 1.7 and 4.4% on 10/25, 7/26 and 2/22 and a gain of 9.7% on 4/26. The stock is now consolidating a very large loss of 45% during a 4 week losing streak the weeks ending between 10/5-26. It is higher 4 of the last 6 weeks, with 2 double digit weekly gains and still trades 37% off most recent 52 week highs. Enter NVCR with buy stop above symmetrical triangle, that aligns with rising 200 day SMA, at 34.30.

Trigger NVCR 34.30.  Stop 32.

Taking a present look at the name it rose 47.5% from the recommended entry to the highs made just above 50 last week. It has fallen each day this week, and has dropped more than 5% this week so far, including 2.1% on a firm tape Wednesday. That can be forgiven as it has advanced by a combined 56% during the current 5 week winning streak. A new add on entry is taking shape in the form of a handle on a deep cup base and add to through 50.68.

If you liked what you read why not visit www.chartsmarter.com.